{"id":888049,"date":"2025-09-19T14:39:57","date_gmt":"2025-09-19T18:39:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/"},"modified":"2025-09-19T14:39:57","modified_gmt":"2025-09-19T18:39:57","slug":"berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/","title":{"rendered":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n PHILADELPHIA<\/span>
\n <\/span>, Sept. 19, 2025<\/span><\/span> \/PRNewswire\/ — Berger Montague<\/span><\/a><\/u>, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc.<\/b> (“Hims & Hers” or the “Company”) (NYSE: HIMS<\/b>) about an investigation into Hims & Hers’ Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A\/S’s termination of its partnership with Hims & Hers.\u00a0<\/p>\n

\n

\n
\n \"A
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n
\n Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague<\/span>: Radha Raghavan<\/span> at <\/i>
\n <\/b>
\n
\n
\n
\n rraghavan@bergermontague.com<\/a>
\n <\/u>
\n <\/i>
\n <\/b>\u00a0or (332) 271-8908, or Andrew Abramowitz<\/span> at aabramowitz@bergermontague.com<\/a><\/u><\/i><\/b>or (215) 875-3015 or by CLICKING HERE<\/a><\/u><\/i><\/b>.<\/i><\/p>\n

\n Berger Montague’s<\/span> investigation is focused on whether Hims & Hers’ Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company’s partnership with Novo Nordisk, including in connection with Novo Nordisk’s announcement in June 2025<\/span> that it was terminating its partnership with Hims & Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.<\/p>\n

\n Berger Montague<\/span>, with offices in Philadelphia<\/span>, Minneapolis<\/span>, Delaware<\/span>, Washington, D.C.<\/span>, San Diego<\/span>, San Francisco<\/span>, Chicago<\/span>, Malvern, PA<\/span>, and Toronto<\/span> has been a pioneer in\u00a0<\/a>securities class action litigation<\/a><\/u> since its founding in 1970. Berger Montague<\/span> has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States<\/span>.<\/p>\n

Contacts:
Radha Raghavan<\/span>, Associate
Berger Montague<\/span>
(332) 271-8908
rraghavan@bergermontague.com<\/a><\/u><\/p>\n

\n Andrew Abramowitz<\/span>, Senior Counsel
Berger Montague<\/span>
(215) 875-3015
aabramowitz@bergermontague.com<\/a><\/u><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/berger-montague-investigates-hims–hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties-302561812.html<\/a><\/p>\n

SOURCE Berger Montague<\/span><\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire PHILADELPHIA , Sept. 19, 2025 \/PRNewswire\/ — Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) about an investigation into Hims & Hers’ Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A\/S’s termination of its partnership with Hims & Hers.\u00a0 Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bergermontague.com \u00a0or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bergermontague.comor (215) 875-3015 or by CLICKING HERE. Berger Montague’s investigation is focused on whether Hims & Hers’ Board of Directors breached its fiduciary duties in … <\/p>\n

Continue reading “Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-888049","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBerger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHILADELPHIA , Sept. 19, 2025 \/PRNewswire\/ — Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) about an investigation into Hims & Hers’ Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A\/S’s termination of its partnership with Hims & Hers.\u00a0 Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bergermontague.com \u00a0or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bergermontague.comor (215) 875-3015 or by CLICKING HERE. Berger Montague’s investigation is focused on whether Hims & Hers’ Board of Directors breached its fiduciary duties in … Continue reading "Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T18:39:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties\",\"datePublished\":\"2025-09-19T18:39:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/\",\"name\":\"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"datePublished\":\"2025-09-19T18:39:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/","og_locale":"en_US","og_type":"article","og_title":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk","og_description":"PR Newswire PHILADELPHIA , Sept. 19, 2025 \/PRNewswire\/ — Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) about an investigation into Hims & Hers’ Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A\/S’s termination of its partnership with Hims & Hers.\u00a0 Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bergermontague.com \u00a0or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bergermontague.comor (215) 875-3015 or by CLICKING HERE. Berger Montague’s investigation is focused on whether Hims & Hers’ Board of Directors breached its fiduciary duties in … Continue reading \"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-19T18:39:57+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties","datePublished":"2025-09-19T18:39:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/","name":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","datePublished":"2025-09-19T18:39:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/berger-montague-investigates-hims-hers-health-inc-nyse-hims-board-of-directors-for-potential-breaches-of-fiduciary-duties\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=888049"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888049\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=888049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=888049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=888049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}